Simultaneous analysis of urinary total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol, N′-nitrosonornicotine, and cotinine by liquid chromatography-tandem mass-spectrometry

Abstract Biomarkers of exposure to harmful tobacco constituents are key tools for identifying individuals at risk and developing interventions and tobacco control measures. However, tobacco biomarker studies are scarce in many parts of the world with high prevalence of tobacco use. Our goal was to e...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sampada S. Nikam, Murari Gurjar, Hitesh Singhavi, Anand Patil, Arjun Singh, Peter Villalta, Pankaj Chaturvedi, Samir S. Khariwala, Vikram Gota, Irina Stepanov
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/45e09be7e7914e3c8b4c11f4d51e5b1c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:45e09be7e7914e3c8b4c11f4d51e5b1c
record_format dspace
spelling oai:doaj.org-article:45e09be7e7914e3c8b4c11f4d51e5b1c2021-12-02T16:57:08ZSimultaneous analysis of urinary total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol, N′-nitrosonornicotine, and cotinine by liquid chromatography-tandem mass-spectrometry10.1038/s41598-021-99259-z2045-2322https://doaj.org/article/45e09be7e7914e3c8b4c11f4d51e5b1c2021-10-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-99259-zhttps://doaj.org/toc/2045-2322Abstract Biomarkers of exposure to harmful tobacco constituents are key tools for identifying individuals at risk and developing interventions and tobacco control measures. However, tobacco biomarker studies are scarce in many parts of the world with high prevalence of tobacco use. Our goal was to establish a robust method for simultaneous analysis of urinary total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL), N′-nitrosonornicotine (NNN), and cotinine at the Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) in Mumbai, India. These biomarkers are validated measures of exposure to the carcinogenic tobacco nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and NNN and the addictive alkaloid nicotine, respectively. The established method is characterized by excellent accuracy, linearity, and precision, and was successfully applied to the analysis of 15 smokeless tobacco (SLT) users and 15 non-users of tobacco recruited in Mumbai. This is the first report of establishment of such procedure in a laboratory in India, which offers the first in-country capacity for research on tobacco carcinogenesis in Indian SLT users.Sampada S. NikamMurari GurjarHitesh SinghaviAnand PatilArjun SinghPeter VillaltaPankaj ChaturvediSamir S. KhariwalaVikram GotaIrina StepanovNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Sampada S. Nikam
Murari Gurjar
Hitesh Singhavi
Anand Patil
Arjun Singh
Peter Villalta
Pankaj Chaturvedi
Samir S. Khariwala
Vikram Gota
Irina Stepanov
Simultaneous analysis of urinary total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol, N′-nitrosonornicotine, and cotinine by liquid chromatography-tandem mass-spectrometry
description Abstract Biomarkers of exposure to harmful tobacco constituents are key tools for identifying individuals at risk and developing interventions and tobacco control measures. However, tobacco biomarker studies are scarce in many parts of the world with high prevalence of tobacco use. Our goal was to establish a robust method for simultaneous analysis of urinary total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL), N′-nitrosonornicotine (NNN), and cotinine at the Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) in Mumbai, India. These biomarkers are validated measures of exposure to the carcinogenic tobacco nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and NNN and the addictive alkaloid nicotine, respectively. The established method is characterized by excellent accuracy, linearity, and precision, and was successfully applied to the analysis of 15 smokeless tobacco (SLT) users and 15 non-users of tobacco recruited in Mumbai. This is the first report of establishment of such procedure in a laboratory in India, which offers the first in-country capacity for research on tobacco carcinogenesis in Indian SLT users.
format article
author Sampada S. Nikam
Murari Gurjar
Hitesh Singhavi
Anand Patil
Arjun Singh
Peter Villalta
Pankaj Chaturvedi
Samir S. Khariwala
Vikram Gota
Irina Stepanov
author_facet Sampada S. Nikam
Murari Gurjar
Hitesh Singhavi
Anand Patil
Arjun Singh
Peter Villalta
Pankaj Chaturvedi
Samir S. Khariwala
Vikram Gota
Irina Stepanov
author_sort Sampada S. Nikam
title Simultaneous analysis of urinary total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol, N′-nitrosonornicotine, and cotinine by liquid chromatography-tandem mass-spectrometry
title_short Simultaneous analysis of urinary total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol, N′-nitrosonornicotine, and cotinine by liquid chromatography-tandem mass-spectrometry
title_full Simultaneous analysis of urinary total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol, N′-nitrosonornicotine, and cotinine by liquid chromatography-tandem mass-spectrometry
title_fullStr Simultaneous analysis of urinary total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol, N′-nitrosonornicotine, and cotinine by liquid chromatography-tandem mass-spectrometry
title_full_unstemmed Simultaneous analysis of urinary total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol, N′-nitrosonornicotine, and cotinine by liquid chromatography-tandem mass-spectrometry
title_sort simultaneous analysis of urinary total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol, n′-nitrosonornicotine, and cotinine by liquid chromatography-tandem mass-spectrometry
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/45e09be7e7914e3c8b4c11f4d51e5b1c
work_keys_str_mv AT sampadasnikam simultaneousanalysisofurinarytotal4methylnitrosamino13pyridyl1butanolnnitrosonornicotineandcotininebyliquidchromatographytandemmassspectrometry
AT murarigurjar simultaneousanalysisofurinarytotal4methylnitrosamino13pyridyl1butanolnnitrosonornicotineandcotininebyliquidchromatographytandemmassspectrometry
AT hiteshsinghavi simultaneousanalysisofurinarytotal4methylnitrosamino13pyridyl1butanolnnitrosonornicotineandcotininebyliquidchromatographytandemmassspectrometry
AT anandpatil simultaneousanalysisofurinarytotal4methylnitrosamino13pyridyl1butanolnnitrosonornicotineandcotininebyliquidchromatographytandemmassspectrometry
AT arjunsingh simultaneousanalysisofurinarytotal4methylnitrosamino13pyridyl1butanolnnitrosonornicotineandcotininebyliquidchromatographytandemmassspectrometry
AT petervillalta simultaneousanalysisofurinarytotal4methylnitrosamino13pyridyl1butanolnnitrosonornicotineandcotininebyliquidchromatographytandemmassspectrometry
AT pankajchaturvedi simultaneousanalysisofurinarytotal4methylnitrosamino13pyridyl1butanolnnitrosonornicotineandcotininebyliquidchromatographytandemmassspectrometry
AT samirskhariwala simultaneousanalysisofurinarytotal4methylnitrosamino13pyridyl1butanolnnitrosonornicotineandcotininebyliquidchromatographytandemmassspectrometry
AT vikramgota simultaneousanalysisofurinarytotal4methylnitrosamino13pyridyl1butanolnnitrosonornicotineandcotininebyliquidchromatographytandemmassspectrometry
AT irinastepanov simultaneousanalysisofurinarytotal4methylnitrosamino13pyridyl1butanolnnitrosonornicotineandcotininebyliquidchromatographytandemmassspectrometry
_version_ 1718382621851910144